A study of the microbiology of diabetic foot infections in a teaching hospital in Kuwait

Journal of Infection and Public Health

Volumn 5, Issue 1, 2012, Pages 1-8

  Benwan, Khalifa Al ^a   Mulla, Ahmed Al ^a   Rotimi, Vincent O ^b  

^a AL AMIRI HOSPITAL   (Kuwait)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antibiotic susceptibility; Diabetic foot; Etiology; Infections

Indexed keywords

AMIKACIN; AMPICILLIN; CLINDAMYCIN; CLOXACILLIN; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; FUSIDIC ACID; GENTAMICIN; IMIPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AEROBIC BACTERIUM; AGED; ANAEROBE; ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC FOOT INFECTION; DRUG EFFICACY; ENTEROCOCCUS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; INFORMATION PROCESSING; KUWAIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STANDARD; STAPHYLOCOCCUS AUREUS; TEACHING HOSPITAL;

ADULT; ANTI-BACTERIAL AGENTS; COINFECTION; DIABETES COMPLICATIONS; DIABETIC FOOT; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; KUWAIT; MICROBIAL SENSITIVITY TESTS;

EID: 84857110842     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2011.07.004     Document Type: Article

References (15)

1. Moussa M.A., Alsaeid M., Abdella N., Refai T.M., Al-Sheikh N., Gomez J.E. Prevalence of type 2 diabetes mellitus among Kuwaiti children and adolescents. Med Princ Pract 2008, 17:270-275.
2. Zaini A. Where is Malaysia in the midst of the Asian epidemic of diabetes mellitus?. Diabetes Res Clin Pract 2000, 50(Suppl. 2):S23-S28.
3. Ramsey S.D., Newton K., Blough D., McCulloch D.K., Sandhu N., Reiber G.E., et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999, 22:287-382.
4. Jeffcoate W.J., Harding K.G. Diabetic foot ulcers. Lancet 2003, 361:1545-1551.
5. Lipsky B.A. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 2004, 20(Suppl. 1):S68-S77.
6. Frykberg R.G. An evidence-based approach to diabetic foot infections. Am J Surg 2003, 186:44S-54S.
7. Lipsky B.A., Berendt A.R., Deery H.G., Embil J.M., Joseph W.S., Karchmer A.W., et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004, 39:885-910.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk tests. Approved Standards, 9th ed. CLSI Document M2-A9, vol. 26, no. 1. Wayne, PA, USA.
9. Goldstein J.C., Citron V., Lipsky B.A., Abramson M.A. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. Journal of Clinical Microbiology 2007, 45(9):2819-2828.
10. Mantey I., Hill R.L., Foster A.V., Welson S., Wade J.J., Edmonds M.E. Infection with foot ulcers with Staphylococcus aureus associated with increase mortality in diabetic patients. Commun Dis Public Health 2000, 3:288-290.
11. Abdulrazak A., Bitar Z.I., Al-Shamali A.A., Mobasher L.A. Bacteriological study of diabetic foot infections. J Diabet Complications 2005, 19:138-141.
12. Goldstein E.J., Citron D.M., Nesbit C.A. Diabetic foot infections: bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care 1996, 19:638-664.
13. Kajetan M., Konkoly T.M., Jermendy G. Experience with microbiologic studies of diabetic foot. Orv Hetil 1995, 136:2161-2164.
14. El-Tahawy A.T. Bacteriology of diabetic foot. Saudi Med J 2000, 21:344-347.
15. Warren Y.A., Tyrrell K.L., Citron D.M., Goldstein E.J. Clostridium aldenense sp nov. and Clostridium citroniae sp. nov. isolated from human clinical infections. J Clin Microbiol 2006, 44:2416-2422.